Pulmonx(LUNG)

Search documents
Pulmonx(LUNG) - 2022 Q1 - Quarterly Report
2022-05-09 20:28
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 77-0424412 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 700 Chesapeake Drive Redwood City, California 94063 1-650-364-0400 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) For the quarte ...
Pulmonx(LUNG) - 2022 Q1 - Earnings Call Transcript
2022-05-07 14:08
Pulmonx Corporation (NASDAQ:LUNG) Q1 2022 Results Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Brian Johnston - VP, Investor Relations, Gilmartin Group Glendon French - President & Chief Executive Officer Derrick Sung - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Cecilia Furlong - Morgan Stanley Operator Thank you for standing by, and welcome to the Pulmonx Q1 2022 Earnings Conference Call. At this time, all participants are in a listen-only. A ...
Pulmonx(LUNG) - 2021 Q4 - Annual Report
2022-03-01 21:24
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-39562 PULMONX CORPORATION (Exact name of registrant as specified in its charter) Delaware 77-0424412 (State or other jurisdiction of incorporation or organizati ...
Pulmonx(LUNG) - 2021 Q4 - Earnings Call Presentation
2022-02-25 22:55
NASDAQ: LUNG February 2022 © 2022 Pulmonx Corporation1 Forward Looking Statement This presentation and certain statements made during this presentation contain forward-looking statements that involve risks and uncertainties. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business ...
Pulmonx(LUNG) - 2021 Q4 - Earnings Call Transcript
2022-02-24 03:36
Pulmonx Corporation (NASDAQ:LUNG) Q4 2021 Earnings Conference Call February 23, 2022 4:30 PM ET Company Participants Glen French - President & Chief Executive Officer Derrick Sung - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Rick Wise - Stifel Operator Ladies and gentlemen, thank you for standing by and welcome to the Pulmonx Quarter Four 2021 Earnings Conference Call. At this time, all participants are in a listen-only. Later, we will conduct a question-and-answer ses ...
Pulmonx (LUNG) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference
2022-01-12 21:06
NASDAQ: LUNG January 2022 © 2022 Pulmonx Corporation1 Forward Looking Statement This presentation and certain statements made during this presentation contain forward-looking statements that involve risks and uncertainties. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business s ...
Pulmonx(LUNG) - 2021 Q3 - Quarterly Report
2021-11-09 21:13
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39562 PULMONX CORPORATION (Exact name of registrant as specified in its charter) Delaware 77-0424412 (State or other ...
Pulmonx(LUNG) - 2021 Q3 - Earnings Call Transcript
2021-11-03 02:44
Pulmonx Corporation (NASDAQ:LUNG) Q3 2021 Earnings Conference Call November 2, 2021 4:30 PM ET Company Participants Brian Johnston - Investor Relations, Gilmartin Group Glen French - President & Chief Executive Officer Derrick Sung - Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Bob Hopkins - Bank of America Cecilia Furlong - Morgan Stanley Rick Wise - Stifel Bill Plovanic - Canaccord Genuity Joanne Wuensch - Citibank Jason Bednar - Piper Sandler Operator Good day. Thank ...
Pulmonx(LUNG) - 2021 Q2 - Quarterly Report
2021-08-10 20:39
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39562 PULMONX CORPORATION (Exact name of registrant as specified in its charter) Delaware 77-0424412 (State or other juri ...
Pulmonx(LUNG) - 2021 Q2 - Earnings Call Transcript
2021-08-07 11:09
Pulmonx Corporation (NASDAQ:LUNG) Q2 2021 Earnings Conference Call August 3, 2021 4:30 PM ET Company Participants Brian Johnston - IR, Gilmartin Group Glen French - President and CEO Derrick Sung - CFO Conference Call Participants Bob Hopkins - BofA Securities, Inc. Cecilia Furlong - Morgan Stanley Larry Biegelsen - Wells Fargo Securities Rick Wise - Stifel Financial Corp Bill Plovanic - Canaccord Genuity Jason Bednar - Piper Sandler Joanne Wuensch - Citi Operator Good afternoon. Thank you for standing by, ...